SRDX Surmodics Inc. Total Debt to Capital

A specialized climate-controlled courier service ensures the supply reliability of Surmodics, Inc. (SRDX) cardiac surgery products. This chart of the share price on GURU.Markets shows that the debt-to-equity ratio is 0.31. This correlates with the completion of the asset portfolio restructuring and the decision to forgo new deals. Unique biopolymer patents make Surmodics, Inc. (SRDX) an indispensable B2B supplier for the industry's largest players.

Surmodics, Inc. maintains a dominant position in the medical device chemical coatings niche by integrating its formulas into industry standards. The current debt-to-equity ratio, equal to 0.31, reflects the proportion of borrowed funds relative to shareholders' equity. This metric measures financial leverage and the business's reliance on external financing. An increase in this indicator signals rising risks as borrowing costs climb. A stable level of this metric confirms the resilience of a model based on long-term contracts.